China Resources Gosun Pharmaceutical (002317.SZ) released its performance for the first half of the year, with a net profit of 188 million yuan, a year-on-year increase of 114.96%.

Wisdom Financial News APP, Zhongsheng Pharmaceutical (002317.SZ) released its 2025 semi-annual report. During the reporting period, the company achieved operating income of 1.3 billion yuan, a year-on-year decrease of 4.74%. Net profit attributable to the company's shareholders was 188 million yuan, an increase of 114.96% year-on-year. Net profit attributable to the company's shareholders after deducting non-recurring gains and losses was 187 million yuan, an increase of 7.42% year-on-year. Basic earnings per share were 0.22 yuan.